Mega Chill has become the first medical marijuana dispensary in Canada to accept bitcoin. Since the formal announcement this September, Mega Chill has seen an overwhelmingly positive response from the community, both from patients familiar with bitcoin and customers who had never heard of the digital currency. The relationship between bitcoin and the marijuana industry…
Microsoft Corporation (NASDAQ MSFT) announced this week that it paid $2.5 billion to acquire Swedish gaming company Mojang, maker of the popular Minecraft game. Analysts are starting to weigh in on that deal, and those at Morgan Stanley think it’s a smart way for the company to use its offshore cash. Some investors may be…
Google’s (NASDAQ GOOG) Chrome OS has attracted a great deal of attention in recent months. Chrome OS-powered laptops- Chromebooks- are often much cheaper than alternatives running Microsoft’s Windows, and yet still quite capable. Most of Microsoft’s hardware partners have embraced Google’s cloud-based operating system, while schools have emerged as a hotbed of demand. Still, Chromebook’s…
Ever since the dawn of the age of computers, computing technology has slowly been integrating its way into our lives. First computers entered into the business sphere and universities, then personal homes, then laptops found their way into our backpacks and brief cases. Most recently, with the smartphone revolution, they moved into our pockets. Now,…
Facebook Inc (NASDAQ FB) showed a slight decline in share of overall internet time in August, but the social network is holding steady at a 20% share of mobile minutes. JPMorgan analysts also believe a pickup in brand ads and organic video in the third quarter may give Facebook’s results a boost. Facebook Inc (NASDAQ…
Alexion Pharmaceuticals’ (ALXN) sole marketed product is Soliris (eculizumab). Soliris is available for the treatment of two rare genetic disorders – paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. As the company is entirely dependent on Soliris for growth, it should look to avoid any setback related to the product. However, the FDA seems to…
